Influence of type 2 sodium-glucose co-transporter inhibitors (dapagliflozin) on the indicators of total mortality in patients with type 2 diabetes (CARDIA-MOS study, Moscow)

M. B. Antsiferov; N. A. Demidov; M. A. Balberova; O. V. Lobanova; I. G. Mudrikova; D. G. Gusenbekova

doi:10.14341/DM12929-10227

For citations:

Antsiferov M.B., Demidov N.A., Balberova M.A., Lobanova O.V., Mudrikova I.G., Gusenbekova D.G. Influence of type 2 sodium-glucose co-transporter inhibitors (dapagliflozin) on the indicators of total mortality in patients with type 2 diabetes (CARDIA-MOS study, Moscow). Diabetes mellitus. 2022;25(5):439-448. https://doi.org/10.14341/DM12929

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0).

ISSN 2072-0351 (Print)
ISSN 2072-0378 (Online)

Username
Password
	Remember me
Not a user? Register with this site Forgot your password?

User

Diabetes mellitus

For citations:

Cookies policy